Rezaei Omidvar, Honarmand Tamizkar Kasra, Hajiesmaeili Mohammadreza, Taheri Mohammad, Ghafouri-Fard Soudeh
Skull Base Research Center, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Front Oncol. 2021 Feb 24;11:617362. doi: 10.3389/fonc.2021.617362. eCollection 2021.
Neuroblastoma is one of the utmost frequent neoplasms during the first year of life. This pediatric cancer is believed to be originated during the embryonic life from the neural crest cells. Previous studies have detected several types of chromosomal aberrations in this tumor. More recent studies have emphasized on expression profiling of neuroblastoma samples to identify the dysregulated genes in this type of cancer. Non-coding RNAs are among the mostly dysregulated genes in this type of cancer. Such dysregulation has been associated with a number of chromosomal aberrations that are frequently detected in neuroblastoma. In this study, we explain the role of non-coding transcripts in the malignant transformation in neuroblastoma and their role as biomarkers for this pediatric cancer.
神经母细胞瘤是一岁以内最常见的肿瘤之一。这种儿科癌症被认为起源于胚胎期的神经嵴细胞。先前的研究已在该肿瘤中检测到几种类型的染色体畸变。最近的研究着重于神经母细胞瘤样本的表达谱分析,以识别这类癌症中失调的基因。非编码RNA是这类癌症中失调最为常见的基因之一。这种失调与神经母细胞瘤中经常检测到的一些染色体畸变有关。在本研究中,我们阐述了非编码转录本在神经母细胞瘤恶性转化中的作用及其作为这种儿科癌症生物标志物的作用。